Hepatic Artery Infusion Pump Chemotherapy for Liver Metastases From Resected Pancreatic and Duodenal Adenocarcinoma
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this observational study is to evaluate whether hepatic artery infusion pump (HAIP) chemotherapy can improve outcomes in patients with pancreatic or duodenal adenocarcinoma who have isolated or liver-dominant metastases after surgery and systemic chemotherapy. The main questions it aims to answer are: Does HAIP chemotherapy improve liver tumor response based on imaging criteria (RECIST)? What are the progression-free survival and overall survival outcomes in this patient population? Participants will: Undergo placement of a hepatic artery infusion pump as part of standard clinical care Receive floxuridine (FUDR)-based chemotherapy through the pump Have clinical data, imaging results, and laboratory markers (e.g., ctDNA, CEA, CA 19-9) collected from their medical records over time
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjent ma od 18 do 80 lat.
- •Potwierdzony histopatologicznie rak trzustki lub dwunastnicy.
- •Pacjent zakończył lub jest w trakcie leczenia z celem wyleczenia.
- •Stwierdzono przerzuty tylko do wątroby lub przerzuty dominujące w wątrobie (widoczne na obrazach lub potwierdzone klinicznie).
- •Zespół lekarzy uznał, że pacjent kwalifikuje się do wszczepienia pompy do tętnicy wątrobowej i podawania chemioterapii.
- •Pompa do tętnicy wątrobowej ma być wszczepiona w szpitalu AdventHealth Orlando.
✗ Disqualifies
- •Pacjenci, którzy ze względów medycznych nie nadają się do wszczepienia pompy do tętnicy wątrobowej lub otrzymania chemioterapii.
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 80 Years
- Last updated (source)
- September 29, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
AdventHealth Orlando
Orlando, United States
Trial contact
Maggie Polanco, RN
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/30/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.